Mary Potter Oncology Centre

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Melanoma3 trials
• Colorectal cancer1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial

Phase

• Phase 33 trials
• Phase 11 trial

Status

• Completed3 trials
• Terminated1 trial

Lead sponsor

• Incyte Corporation2 trials
• Amgen1 trial
• Pfizer1 trial

Closed trials

• Terminated

  Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

  NCT05909995· Phase 1· Incyte Corporation· Source

• Completed

  A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

  NCT05907122· Phase 3· Amgen· Source

• Completed

  Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

  NCT04205812· Phase 3· Incyte Corporation· Source

• Completed

  Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

  NCT01909453· Phase 3· Pfizer· Source